PIMCO Income Strategy Fund/ US72201H1086 /
29.05.2024 22:10:00 | Diff. -0.03 | Volumen | Geld02:00:00 | Brief02:00:00 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
8.26USD | -0.36% | 85'148 Umsatz: 665'052.57 |
8.17Geld Vol: 100 | 8.38Brief Vol: 100 | 8.30 | 8.26 |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite